Benzinga | Nov 4, 2020 04:02PM EST

TransMedics Group Q3 EPS $(0.19) Beats $(0.32) Estimate, Sales $7.09M Beat $5.55M Estimate

TransMedics Group (NASDAQ:TMDX) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.32) by 40.63 percent. This is a 51.28 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $7.09 million which beat the analyst consensus estimate of $5.55 million by 27.77 percent. This is a 1.58 percent decrease over sales of $7.21 million the same period last year.